Related Experiment Video
Updated: Sep 16, 2025

10:44
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
13.4K
An Unusual Adverse Drug Reaction to Thalidomide: A Case Report
Akshay Sankar Peethambaran1, Neel Prabha1, Prateek Pujar1
1Department of Dermatology, AIIMS Raipur, Chhattisgarh, 492099, India.
Current Drug Safety
|July 10, 2025
Summary
Thalidomide, a drug with antitumor properties, can cause rare adverse reactions like burning sensations and breathlessness. Clinicians should be aware of these uncommon side effects in patients undergoing treatment.
Area of Science:
- Pharmacology
- Immunology
- Oncology
Background:
- Thalidomide exhibits antiangiogenic and immunomodulatory properties, making it a novel antitumor agent.
- Despite past safety concerns, thalidomide is now approved for erythema nodosum leprosum under strict guidelines.
- Common adverse effects include neuropathy, teratogenicity, fatigue, and gastrointestinal issues.
Observation:
- A 46-year-old female with lepromatous leprosy on multidrug therapy experienced unusual symptoms.
- The patient presented with a generalized burning sensation, breathlessness, and low backache.
- These reactions occurred after the initiation of thalidomide treatment.
Findings:
- The case highlights an uncommonly reported adverse reaction to thalidomide.
- Symptoms included generalized burning sensation, dyspnea, and low back pain.
- These symptoms were not previously documented as side effects in existing literature.
Implications:
- Alerts clinicians to consider these unusual adverse reactions to thalidomide.
- Emphasizes the importance of monitoring patients for atypical side effects.
- Contributes to a comprehensive understanding of thalidomide's safety profile in leprosy treatment.
Related Concept Videos
Pharmacovigilance
999
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
999
Teratogenicity
2.8K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K
Allergic Drug Reactions
983
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
983
Drug Regulation
1.9K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.9K
Desensitization and Tachyphylaxis
2.2K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.2K
Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K

